Published in Hypertension on November 20, 1980
The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med (2010) 1.84
The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol (1985) 1.28
Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats. Ther Adv Cardiovasc Dis (2012) 0.85
The cardiovascular response of normal rats to dual lesion of the subfornical organ and area postrema at rest and to chronic losartan. Brain Res (2009) 0.78
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation (2000) 1.93
Counterregulatory actions of angiotensin-(1-7). Hypertension (1997) 1.87
Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens (1996) 1.73
Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci (1997) 1.71
Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension (1999) 1.62
Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension (1996) 1.48
Differential actions of renal ischemic injury on the intrarenal angiotensin system. Am J Physiol Renal Physiol (2000) 1.45
Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues. Am J Physiol Renal Physiol (2000) 1.45
Effects of vascular stent surface area and hemodynamics on intimal thickening. J Vasc Interv Radiol (1996) 1.43
Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Physiol (1984) 1.41
Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension (1996) 1.40
In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension (1992) 1.31
A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci (1993) 1.31
Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension (1998) 1.29
Angiotensin II acts at AT1 receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex. Am J Physiol (1998) 1.28
Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol (1995) 1.27
Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides (1994) 1.26
Initial coronary air embolus in the differential diagnosis of coronary artery spasm. Am J Cardiol (1985) 1.24
Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem (1989) 1.23
Bone and Joint tuberculosis in Greater Manchester 1969-79. Ann Rheum Dis (1982) 1.23
Pathophysiology of intravenous air embolism in dogs. Anesthesiology (1978) 1.22
Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol (1997) 1.21
Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension (1998) 1.21
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension (1998) 1.19
State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension (1999) 1.18
Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats. Am J Physiol (1989) 1.16
Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension (1997) 1.16
Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci U S A (1988) 1.13
Baroreceptor reflex modulation by angiotensin II at the nucleus tractus solitarii. Hypertension (1988) 1.12
Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension (1998) 1.11
Cardiovascular actions of angiotensin(1-7). Peptides (1993) 1.11
Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension (1999) 1.11
Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol (1996) 1.11
Reassessment of plasma angiotensins measurement: effects of protease inhibitors and sample handling procedures. Peptides (1992) 1.11
Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res (1994) 1.08
Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus. Am J Physiol (1994) 1.06
Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension (1995) 1.06
Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta (2005) 1.05
Cardiovascular effects of angiotensin mediated by the central nervous system. Circ Res (1972) 1.04
Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension (1995) 1.04
Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.04
Production of angiotensin-(1-7) by human vascular endothelium. Hypertension (1992) 1.03
Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J (1996) 1.03
Angiotensin-(1-7). A member of circulating angiotensin peptides. Hypertension (1991) 1.02
Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. J Cardiovasc Pharmacol (2000) 1.00
Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). Hypertension (1995) 1.00
Evidence for an intrinsic angiotensin system in the canine pancreas. J Hypertens (1991) 0.99
Reactivation of tuberculosis after total hip replacement. J Bone Joint Surg Br (1979) 0.98
Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension (1991) 0.98
The reliability of ERP components in the auditory oddball paradigm. Psychophysiology (1993) 0.98
Bi-directional actions of estrogen on the renin-angiotensin system. Braz J Med Biol Res (1999) 0.97
Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension (1997) 0.96
Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition. Hypertension (2000) 0.95
Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol (1991) 0.94
Central vasomotor stimulation by angiotensin. Clin Sci (1970) 0.94
Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. Am J Hypertens (1998) 0.93
Decisional balance regarding substance use among persons with schizophrenia. Community Ment Health J (1999) 0.93
Converting enzyme activity and angiotensin metabolism in the dog brainstem. Hypertension (1988) 0.92
Sexual dysfunction in hypertensive patients treated with losartan. Am J Med Sci (2001) 0.92
Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. J Am Coll Cardiol (2001) 0.92
Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am J Physiol (1994) 0.92
Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension (2000) 0.92
Cardiac performance in rats with renal hypertension. Circ Res (1976) 0.91
Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats. Hypertension (2000) 0.91
Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertens (1991) 0.91
Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine (2001) 0.90
Pathways of angiotensin-(1-7) metabolism in the kidney. Nephrol Dial Transplant (2001) 0.90
Angiotensin-(1-7) immunoreactivity in the hypothalamus of the (mRen-2d)27 transgenic rat. Brain Res (1998) 0.90
Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma. J Urol (1994) 0.89
Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension (1991) 0.89
Flow velocity variations in the pulmonary veins of the dog. Invest Radiol (1968) 0.89
Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats. Hypertension (1993) 0.88
Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res (1998) 0.88
Adrenal, kidney, and heart angiotensins in female murine Ren-2 transfected hypertensive rats. Peptides (1998) 0.88
Angiotensin II receptor localization in the canine CNS. Brain Res (1985) 0.87
Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats. J Cardiovasc Pharmacol (1998) 0.87
Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage. Curr Med Res Opin (2000) 0.87
Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc Natl Acad Sci U S A (1990) 0.87
Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides (1994) 0.87